- Home
- HEPA vs SBET Comparison
HEPA vs SBET Comparison
Compare HEPA & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- SBET
- Stock Information
- Founded
- HEPA 2013
- SBET 1995
- Country
- HEPA United States
- SBET United States
- Employees
- HEPA N/A
- SBET N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- HEPA Health Care
- SBET Technology
- Exchange
- HEPA Nasdaq
- SBET Nasdaq
- Market Cap
- HEPA 1.7M
- SBET 1.6M
- IPO Year
- HEPA N/A
- SBET 1997
- Fundamental
- Price
- HEPA $0.17
- SBET $0.45
- Analyst Decision
- HEPA
- SBET
- Analyst Count
- HEPA 0
- SBET 0
- Target Price
- HEPA N/A
- SBET N/A
- AVG Volume (30 Days)
- HEPA 31.4M
- SBET 3.6M
- Earning Date
- HEPA 04-15-2025
- SBET 11-15-2024
- Dividend Yield
- HEPA N/A
- SBET N/A
- EPS Growth
- HEPA N/A
- SBET N/A
- EPS
- HEPA N/A
- SBET 1.81
- Revenue
- HEPA N/A
- SBET $3,866,015.00
- Revenue This Year
- HEPA N/A
- SBET N/A
- Revenue Next Year
- HEPA N/A
- SBET N/A
- P/E Ratio
- HEPA N/A
- SBET $0.48
- Revenue Growth
- HEPA N/A
- SBET 56.18
- 52 Week Low
- HEPA $0.12
- SBET $0.33
- 52 Week High
- HEPA $3.33
- SBET $1.68
- Technical
- Relative Strength Index (RSI)
- HEPA 36.41
- SBET 42.21
- Support Level
- HEPA $0.17
- SBET $0.46
- Resistance Level
- HEPA $0.19
- SBET $0.56
- Average True Range (ATR)
- HEPA 0.02
- SBET 0.08
- MACD
- HEPA 0.01
- SBET 0.01
- Stochastic Oscillator
- HEPA 28.55
- SBET 32.19
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the Company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The Company has two operating segments: Affiliate Marketing Services-United States and Affiliate Marketing Services-International. The company generates the majority of the revenue earned from the Affiliate Marketing Services-International segment.